Mark Kockx

14.9k total citations
176 papers, 9.2k citations indexed

About

Mark Kockx is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mark Kockx has authored 176 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 54 papers in Molecular Biology and 53 papers in Immunology. Recurrent topics in Mark Kockx's work include Cancer Immunotherapy and Biomarkers (29 papers), Atherosclerosis and Cardiovascular Diseases (27 papers) and Cancer Genomics and Diagnostics (17 papers). Mark Kockx is often cited by papers focused on Cancer Immunotherapy and Biomarkers (29 papers), Atherosclerosis and Cardiovascular Diseases (27 papers) and Cancer Genomics and Diagnostics (17 papers). Mark Kockx collaborates with scholars based in Belgium, United States and Netherlands. Mark Kockx's co-authors include Guido R.Y. De Meyer, Wim Martinet, Arnold G. Herman, Michiel Knaapen, Hidde Bult, D. Schrijvers, Luc Andries, Willem Jacob, Hilde Bortier and A.G. Herman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Mark Kockx

174 papers receiving 9.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kockx Belgium 54 3.4k 2.5k 1.9k 1.5k 1.4k 176 9.2k
Erik A.L. Biessen Netherlands 56 4.7k 1.4× 4.2k 1.7× 1.5k 0.8× 1.6k 1.0× 1.6k 1.1× 249 11.0k
Ulf Hedin Sweden 52 4.0k 1.2× 3.3k 1.3× 1.7k 0.9× 1.3k 0.8× 1.8k 1.3× 216 10.2k
Anthony J. Valente United States 55 2.9k 0.8× 3.2k 1.3× 1.5k 0.8× 1.1k 0.7× 1.0k 0.7× 122 8.9k
Mark B. Taubman United States 56 3.1k 0.9× 1.9k 0.8× 1.7k 0.9× 668 0.4× 1.5k 1.1× 115 9.1k
Brenda R. Kwak Switzerland 50 5.0k 1.5× 1.8k 0.7× 1.6k 0.8× 809 0.5× 747 0.5× 149 9.3k
Clemens D. Cohen Germany 57 3.7k 1.1× 2.1k 0.8× 1.1k 0.6× 878 0.6× 1.0k 0.7× 146 9.8k
Robert L. Reddick United States 44 2.3k 0.7× 1.9k 0.8× 2.1k 1.1× 966 0.6× 869 0.6× 148 8.9k
Luis Miguel Blanco‐Colio Spain 51 2.9k 0.9× 2.0k 0.8× 1.9k 1.0× 867 0.6× 1.6k 1.1× 193 7.9k
David J. Nikolic‐Paterson Australia 70 5.9k 1.7× 4.7k 1.9× 2.5k 1.3× 1.1k 0.7× 894 0.6× 244 17.6k
G. Rothe Germany 39 3.6k 1.1× 2.4k 1.0× 2.4k 1.2× 863 0.6× 1.3k 0.9× 102 9.0k

Countries citing papers authored by Mark Kockx

Since Specialization
Citations

This map shows the geographic impact of Mark Kockx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kockx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kockx more than expected).

Fields of papers citing papers by Mark Kockx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kockx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kockx. The network helps show where Mark Kockx may publish in the future.

Co-authorship network of co-authors of Mark Kockx

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kockx. A scholar is included among the top collaborators of Mark Kockx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kockx. Mark Kockx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Li, Jeffrey Eastham, Jennifer M. Giltnane, et al.. (2024). Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy. The Journal of Pathology. 263(2). 190–202. 6 indexed citations
2.
Awada, Gil, et al.. (2024). Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAFV600/NRASQ61 Wild-Type Melanoma (TraMel-WT). JCO Precision Oncology. 8(8). e2300493–e2300493. 4 indexed citations
3.
Kockx, Mark, Bauke Ylstra, Stephen P. Finn, et al.. (2023). False positivity in break apart fluorescence in-situ hybridization due to polyploidy. Translational Lung Cancer Research. 12(4). 676–688. 5 indexed citations
4.
Muilwijk, Tim, Murat Akand, Sofie Daelemans, et al.. (2021). Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer. PLoS ONE. 16(9). e0257195–e0257195. 9 indexed citations
5.
Wagle, Marie-Claire, Joseph Castillo, Shrividhya Srinivasan, et al.. (2020). Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer. Cancer Immunology Research. 8(7). 844–850. 6 indexed citations
6.
Stremitzer, Stefan, Peter Vermeulen, Mark Kockx, et al.. (2020). Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. British Journal of Cancer. 122(10). 1518–1524. 31 indexed citations
7.
Awada, Gil, Julia Katharina Schwarze, Yanina Jansen, et al.. (2020). Baseline biomarkers correlated with outcome in advanced melanoma treated with pembrolizumab monotherapy.. Journal of Clinical Oncology. 38(15_suppl). e22041–e22041. 3 indexed citations
8.
Wongchenko, Matthew, Grant A. McArthur, Brigitte Dréno, et al.. (2017). Gene Expression Profiling in BRAF -Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib. Clinical Cancer Research. 23(17). 5238–5245. 28 indexed citations
9.
Gevaert, Thomas, Rodolfo Montironi, Antonio López-Beltrán, et al.. (2017). Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment. Seminars in Cancer Biology. 52(Pt 2). 216–227. 12 indexed citations
10.
Seremet, Teofila, Alexander Koch, Yanina Jansen, et al.. (2016). Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients. Journal of Translational Medicine. 14(1). 232–232. 24 indexed citations
11.
Dowsett, Mitch, Wedad Hanna, Mark Kockx, et al.. (2007). Standardization of HER2 testing: results of an international proficiency-testing ring study. Modern Pathology. 20(5). 584–591. 103 indexed citations
12.
Verheye, Stefan, Wim Martinet, Mark Kockx, et al.. (2007). Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy. Journal of the American College of Cardiology. 49(6). 706–715. 159 indexed citations
13.
Backer, A. I. De, et al.. (2005). Tuberculosis of the Pancreas: MRI Features. American Journal of Roentgenology. 184(1). 50–54. 50 indexed citations
14.
Bartúnek, Jozef, et al.. (2002). Deoxyribonucleic acid damage/repairproteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 40(6). 1097–1103. 36 indexed citations
15.
Meyer, Guido R.Y. De, Susan J. Cooper, Michiel Knaapen, et al.. (2002). Platelet Phagocytosis and Processing of β-Amyloid Precursor Protein as a Mechanism of Macrophage Activation in Atherosclerosis. Circulation Research. 90(11). 1197–1204. 119 indexed citations
16.
Soest, Rob W. M. van, et al.. (2001). Description of Agelas cerebrum, a new species and redescription of A. dilata. UvA-DARE (University of Amsterdam). 1 indexed citations
17.
Loo, D. Maroeska W. M. te, L.A.H. Monnens, Lambertus P. van den Heuvel, Marie-Claire Gübler, & Mark Kockx. (2001). Detection of Apoptosis in Kidney Biopsies of Patients with D+ Hemolytic Uremic Syndrome. Pediatric Research. 49(3). 413–416. 12 indexed citations
18.
Verhamme, Peter, Gregor Theilmeier, Stefan Janssens, et al.. (2001). Recovery of endothelial function and coronary plaque stabilisation after lipid lowering in LDL-hypercholesterolaemic pigs. European Heart Journal. 22. 651–651. 2 indexed citations
19.
Martinet, Wim & Mark Kockx. (2001). Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Current Opinion in Lipidology. 12(5). 535–541. 107 indexed citations
20.
Kockx, Mark & Michiel Knaapen. (2000). The role of apoptosis in vascular disease. The Journal of Pathology. 190(3). 267–280. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik A.L. Biessen Breakdown of academic impact, for papers by Ulf Hedin Breakdown of academic impact, for papers by Anthony J. Valente Breakdown of academic impact, for papers by Mark B. Taubman Breakdown of academic impact, for papers by Brenda R. Kwak Breakdown of academic impact, for papers by Clemens D. Cohen Breakdown of academic impact, for papers by Robert L. Reddick Breakdown of academic impact, for papers by Luis Miguel Blanco‐Colio Breakdown of academic impact, for papers by David J. Nikolic‐Paterson Breakdown of academic impact, for papers by G. Rothe
Rankless by CCL
2026